Efficacy and Bio-availability of Artemether-Lumefantrine in Severely Malnourished Children
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The general objective of the study is to answer to the question: "Is the current dose of AL
less efficacious in the severely malnourished compared to the non-severely malnourished
children, and is PK in cause?" We aim to assess whether the current treatment dose is
adequate for children with severe acute malnutrition, and we hope results will guide further
recommendations for malaria treatment in this specific population.
Phase:
N/A
Details
Lead Sponsor:
Epicentre
Collaborators:
Malaria Research and Training Center, Bamako, Mali University of Cape Town
Treatments:
Artemether Artemether-lumefantrine combination Artemether, Lumefantrine Drug Combination Artemisinins Lumefantrine